ID   INT-MEL-4
AC   CVCL_HE33
SY   Me9874; ME9874
DR   Wikidata; Q54897785
RX   DOI=10.1007/0-306-46872-7_16;
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 8
//
RX   DOI=10.1007/0-306-46872-7_16;
RA   Anichini A., Mortarini R., Vegetti C., Molla A., Borri A., Parmiani G.;
RT   "Melanoma: the Milan melanoma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.283-292; Kluwer Academic Publishers; New York; USA (1999).
//
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RA   Grazia G.;
RT   "Co-targeting of oncogenic and death receptors pathways in human
RT   melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic
RT   strategy.";
RL   Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy.
//
RX   PubMed=9973437; DOI=10.4049/jimmunol.162.3.1739;
RA   Castelli C., Tarsini P., Mazzocchi A., Rini F., Rivoltini L.,
RA   Ravagnani F., Gallino F., Belli F., Parmiani G.;
RT   "Novel HLA-Cw8-restricted T cell epitopes derived from
RT   tyrosinase-related protein-2 and gp100 melanoma antigens.";
RL   J. Immunol. 162:1739-1748(1999).
//